Piper Sandler, a well-known investment firm, increased its price target on shares of Amgen (NASDAQ:AMGN) to $329.00, up from the previous target of $310.00. The firm has maintained its Overweight ...
Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results